A flow-injection method is reported for the determination of thyroxine based on its enhancement effect on the tris(2,2′-bipyridyl)ruthenium(III) chemiluminescence reaction in the presence of NADH using immobilized alcohol dehydrogenase purified from baker yeast. The limit of detection (3σ blank) was 5.0 × 10 -8 M with a sample throughput of 80 h -1 . The calibration graph was linear over the range 0.5 -10 × 10 -7 M (r 2 = 0.9988) with the relative standard deviation in the range 1.4 -3.5% (n = 4). The effect of common excipients used in pharmaceutical preparations, some organic compounds and metal ions was studied. The method was applied to pharmaceutical thyroxine tablets, and the obtained results were not significantly different from the amount quoted. 
Introduction
Thyroxine hormones (3,5,3′,5′-tetraiodothyronine, T4, and 3,5,3′-triiodothyronine, T3) secreted by the pituitary gland are compounds having major biological roles since they are critically important for normal development of the central nervous system in infants, skeletal growth and maturation in children, as well as for the normal function of multiple organ systems in adults. These important hormones are synthesized from L-tyrosine residues in thyroglobulin, a dimeric glycoprotein that constitutes the bulk of the thyroid follicles. 1 Metabolically, these hormones increase the oxygen uptake by mitochondria and heat production; in physiological concentrations both hormones increase synthesis of RNA and protein; in higher doses they act catabolically, causing negative nitrogen balance and mobilization of fat deposits. 2 Numerous methods, such as immunoassays, 3-6 electrochemical, 7, 8 HPLC, 9,1 GC-MS, 10 fluorescence, 11 and electrochemiluminescence, 12 have been reported for the determination of thyroxine in body fluids and pharmaceutical preparations. Beside these, flow injection (FI) methods have also been reported for the determination of thyroxine based on various detection systems. 13, 14 The FI-spectrophotometric method has been reported for the determination of thyroxine to be an inhibitor of immobilized glutamate dehydrogenase. 13 The change in NADH absorbance at 340 nm in the presence of an enzyme and thyroxine is measured online related to the percent inhibition. The relative standard deviation is 1.8% for 8.0 × 10 -6 M thyroxine with the limit of detection 9.0 × 10 -7 M. Another FI-chemiluminescence (FI-CL) method based on quenching of the emission intensity by thyroxine has been reported. 14 The limit of detection (3σ) is 23 μg mL -1 for Lthyroxine with a sample throughput of ≤ 30 h -1 . These methods suffer from poor detection limits, low sample throughput and limited linearity. The production of NADH through appropriate dehydrogenases has also been used for a variety of analytes, e.g., ethanol, cholesterol, glucose, L-lactate and oxalate, based on the electrochemiluminescence detection system. [15] [16] [17] In the present work, a FI method is reported for the determination of thyroxine by its enhancement effect on the Ru(bpy)3 3+ -CL reaction in the presence of NADH produced using immobilized alcohol dehydrogenase. The proposed method has a detection limit (3σ blank) of 5.0 × 10 -8 M with a sample throughput of 80 h -1 . The enzymatic reaction using Ru(bpy)3 3+ -CL; NADH is produced by the following scheme, 18 as given in Fig. 1 , while the initial oxidation of Ru(bpy)3 2+ to Ru(bpy)3 3+ is facilitated by using an online lead dioxide column.
Experimental

Reagents and procedures
Alcohol dehydrogenase (ADH) was isolated and purified from active dry yeast; 280 units mg -1 according to the procedure reported. 19 Controlled porosity glass (CPG, 200 -400 mesh), 3-aminopropyl-triethoxysilane and glutaraldehyde, were obtained from Sigma Chemical Co., USA and used as received. All other reagents were of analytical grade, supplied by Merck BDH, unless stated otherwise, and solutions were prepared in ultra high purity (UHP) deionized water (18.2 MΩ cm -1 , Elgastat, Maxima, UK).
A tris(2,2′-bipyridyl)ruthenium(II) chloride stock solution (1.0 × 10 -3 M) was prepared by dissolving 0.064 g of Ru(bpy)3 2+ (Sigma) in an aqueous solution of sulfuric acid (1.5 × 10 -2 M). A working Ru(bpy)3 2+ solution (1.0 × 10 -4 M) was prepared by diluting 10.0 mL of the stock solution to 100 mL with an aqueous solution of sulfuric acid (1.5 × 10 -2 M). A β-nicotinamide adenine dinucleotide (NAD + , Sigma) stock solution (1.0 × 10 -3 M) was prepared by dissolving 0.067 g of NAD + in 100 mL of water. A working solution (10 × 10 -6 M) was prepared by diluting the required volume of the stock in 100 mL of phosphate buffer (5.0 × 10 -3 M, pH 8.5). A Lthyroxine (3,5,3′,5′-tetraiodothyronine, sodium salt, Fluka) stock solution (1.0 × 10 -3 M) was prepared by dissolving the required amount in 100 mL of sodium hydroxide (0.01 M), sonicated at room temperature for 10 min and working standards were prepared by suitable dilution in phosphate buffer (5.0 × 10 -3 M, pH 8.5), as required. Stock solutions (1.0 × 10 -3 M and 0.1%) of some common excipients of tablets, organic compounds and cations were prepared in UHP water and various working solutions were prepared from these stocks for interference studies. All solutions were protected from light and stored at 4˚C and used whenever required.
Thyroxine tablets were obtained from Eltroxin (Glaxowellcome, New Zealand) and L-thyroxine (Glaxo-wellcome, Pakistan) labeled to contain the same amount (50 μg Lthyroxine tablet -1 ) of levothyroxine sodium salt.
Preparation of crude extract and enzyme purification
Bakers yeast, weighing 100 g of powder was homogenized with 300 mL of phosphate buffer (0.06 M, pH 8.5) for 2 h at room temperature with continuous stirring, and the homogenate was centrifuged at 13000 rpm for 15 min (reextract the residue twice with a considerable yield of ADH). The supernatant was brought to 55˚C for 15 min; after cooling, the mixture was centrifuged and the clear supernatant was stored at 4˚C over night. All further steps of purification were followed as reported previously.
19 Table 1 gives the specific activity and percentage yield for each fraction. One unit of enzyme is defined as the amount of enzyme that converts 1.0 μmol of ethanol to acetaldehyde per min at optimum conditions. Protein was determined by the colorimetric method using bovine serum albumin. 20 
Immobilization procedure
The enzyme used in the present study was immobilized on controlled pore glass (CPG), according to previous procedures. 21, 22 Alcohol dehydrogenase 4.0 mg (280 units mg -1 ) was immobilized in a 0.4 g aliquot of the derivatized glass beads. After the immobilization reaction, the beads were washed twice with 5 -10 mL of phosphate buffer (0.1 M, pH 6.0). The protein content of the washings was measured according to the reported method 20 to evaluate the yield of immobilization on the glass beads.
The immobilized enzyme was packed in a glass column (50 mm × 2.5 mm, i.d.) plugged with cotton wool at both ends. The column was washed with a stream of cold phosphate buffer (0.1 M, pH 7.0) and utilized as needed. When not in use, the column was stored at 4˚C in phosphate buffer (5.0 × 10 -3 M, pH 8.5).
Lead dioxide column
An acid-washed glass column (10 mm × 4.0 mm, i.d.) was packed with solid lead dioxide plugged with cleaned cotton wool at both ends and connected to the FI manifold with silicone tubing. The packed tube was washed with a stream of water for 30 min and incorporated in-line within the FI-CL manifold for Ru(bpy)3 2+ oxidation, as described. 23 Flow system and procedure A FI-CL manifold used for the determination of thyroxine is shown in Fig. 2 . A peristaltic pump (Ismatec, Reglo 100, four channels, Switzerland) was used to propel the sample carrier and reagent solutions at a flow rate of 1. . The PMT, glass coil and T-piece were enclosed in a lighttight housing. 24 The PMT was maintained at an operating voltage of 1020 ± 5 V using a Burle High Voltage Power Supply (2 kV, Type PF 1053, USA). The PMT output was recorded using a chart recorder (Kipp & Zonen BD 40, Switzerland).
Results and Discussion
Yield of the cross-linking method
In the cross-linking procedure, more than 80% of the enzyme incubated with alkylaminated beads was covalently bound to the glass.
About 6 -17% of the protein incubated with 1096 ANALYTICAL SCIENCES AUGUST 2006, VOL. 22 glutaraldehyde-derivatized beads was detected in the supernatant, after the reaction. The immobilized enzyme packed in the glass column was used for 3 months (stored at 4˚C) without any appreciable change in its activity.
Optimization of flow injection system
The FI-CL manifold shown in Fig. 2 was optimized by investigating the effect of various parameters, including the phosphate buffer pH, reagents concentration, flow rate, sample volume and lead dioxide columns length to establish the optimal conditions for the determination of thyroxine based on Ru(bpy)3 3+ -NADH CL reaction. The results are reported in Table 2 and Fig. 3 . All studies were carried out with a 1.0 × 10 -6 M thyroxine solution and a detector (PMT) voltage of 1020 ± 5.0 V.
The effect of the Ru(bpy)3
2+
concentration on the determination of thyroxine was studied over the range 1.0 × 10 -6 -1.0 × 10 -3 M. The CL intensity increased up to 1.0 × 10 -4 M, above which noisy and non-reproducible signals were observed, and therefore a Ru(bpy)3 2+ concentration of 1.0 × 10 -4 M was used for all subsequent experiments. Similarly, sulfuric acid gave the maximum response at 15 × 10 -3 M (range studied 5.0 -25 × 10 -3 M). In the proposed FI-CL system, the effect of the phosphate buffer pH and the concentration on the activity of immobilized alcohol dehydrogenase was investigated. The manageable CL response was observed at pH 8.5 (range studied pH 6.5 -8.5) and a concentration of 5.0 × 10 -3 M (range studied 1.0 -50 × 10 -3 M), as shown in Fig. 3a , and used for all subsequent studies. Ethanol plays a vital role in this enzymatic process. The conversion by the enzyme under physiological conditions is unfavorable; therefore, the ethanol quantity must be large enough to change the direction of the reaction. Therefore, the effect of the ethanol concentrations was studied over the range 0.1 -3.0% prepared in the phosphate buffer (5.0 × 10 -3 M, pH 8.5). An ethanol concentration of 2.0% gave the maximum signal, as shown in Fig. 3b , and was used for subsequent studies. The NAD + concentration of 10 × 10 -6 M gave a suitable response, as given in Fig. 3c , and was used in the experiment (range studied, 1.0 -25 × 10 -6 M).
The effect of flow rate and the sample volume on CL response was calibrated in terms of the speed; sensitivity and reagent consumption. A flow rate of 1.3 mL min -1 gave the maximum CL response with a steady base line and a reproducible peak height, and was used subsequently for all three channels. Similarly, a sample injection volume of 120 μL gave almost the highest CL response and was used for economy of the sample consumption.
The in-line conversion of Ru(bpy)3 2+ to Ru(bpy)3 3+ was achieved chemically by using a solid lead dioxide column. The effect of the column length (ranged studied, (5.0 -20)× 4 mm, i.d.) was investigated for the continuous conversion of Ru(bpy)3 2+ to Ru(bpy)3 3+ for the determination of thyroxine. The maximum CL response was achieved by using a column (10 × 4 mm, i.d.) of solid lead dioxide. Approximately, 4 L of a Ru(bpy)3 2+ solution was passed through this column, and no significant decrease in the CL response was observed in the conversion process.
Analytical figures of merit
The results obtained from quadruplicate injections of thyroxine standards covering the range 0.5 -10 × 10 -7 M under the optimized conditions are shown in Fig. 4 
Interferences
The effect of some organic compounds, common excipients used in pharmaceutical preparations and metal ions on the blank signal (in the absence of thyroxine) and on the determination of L-thyroxine (1.0 × 10 -7 M) are given in Table 3 . Fructose, urea and pyruvate had no significant effect. Ascorbic acid had a slight enhancement effect, while lactose, uric acid, starch and gum acacia significantly enhanced the CL blank signal and had a suppressive effect on the thyroxine response. These enhanced and suppressive effects on both the CL signal blank and on the thyroxine, which may be of high concentrations as well as some of the compounds, are reducing agents. Metal ions including calcium, magnesium, iron(II), zinc(II), and copper(II), had no significant effect, while lead(II) slightly enhanced the CL signal.
Application to pharmaceuticals
The proposed method was applied to commercially available L-thyroxine tablets; Eltroxin (Glaxo-wellcome, New Zealand) and thyroxine (Glaxo-wellcome, Pakistan). The sample was prepared by dissolving each tablet in 50 mL of sodium hydroxide (0.01 M), sonicated for 10 min at room temperature, filtered, diluted 10 times with phosphate buffer (5.0 × 10 -3 M, pH 8.5) and then injected into the proposed FI-CL manifold. The obtained results, given in Table 4 , were in reasonable agreement with the amount quoted.
Conclusions
The developed FI-CL method is simple, rapid (80 h -1 sample throughput) with a limit of detection of 5.0 × 10 -8 M thyroxine. The method was applied to commercially available thyroxine tablets, and the result is in reasonable agreement with the amount of L-thyroxine quoted. The enhancement effect of thyroxine on the Ru(bpy)3 3+ -NADH CL system can further extend its applications to NAD + -NADH converting enzymes and their substrates. In addition, the purification procedure for alcohol dehydrogenase is very simple and economical, and was performed for this purpose. 
